Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.
Journal: Ophthalmology and therapy
Published: January 14, 2026
Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE.
Journal: Ophthalmology science
Published: April 30, 2025
Gene therapy for AMD: better as an adjuvant than a replacement - Authors' reply.
Journal: Lancet (London, England)
Published: January 14, 2025
Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.
Journal: Translational vision science & technology
Published: November 13, 2024
Retinal Vasculopathy and Choroiditis after Pegcetacoplan Injection: Clinicopathologic Support for a Drug Hypersensitivity Reaction.
Journal: Ophthalmology. Retina
Published: July 11, 2024
Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration.
Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: March 11, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance.
Journal: Retina (Philadelphia, Pa.)
Published: March 07, 2024
Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME.
Journal: Translational vision science & technology
Published: October 06, 2023
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.
Journal: Lancet (London, England)
Published: August 18, 2023
Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.
Journal: Ophthalmology
Published: April 18, 2023
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.
Journal: Eye (London, England)
Published: March 11, 2023
Last Updated: 09/26/2026